# Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants

> **NCT00734422** · PHASE2,PHASE3 · COMPLETED · sponsor: **VU University of Amsterdam** · enrollment: 67 (actual)

## Conditions studied

- Phobic Disorders

## Interventions

- **BEHAVIORAL:** Virtual Reality Exposure Therapy

## Key facts

- **NCT ID:** NCT00734422
- **Lead sponsor:** VU University of Amsterdam
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-06
- **Final completion:** 2010-07
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00734422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00734422, "Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00734422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*